NORTHERN TRUST CORP - ARTELO BIOSCIENCES INC ownership

ARTELO BIOSCIENCES INC's ticker is ARTL and the CUSIP is 04301G201. A total of 19 filers reported holding ARTELO BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ARTELO BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$20,000
-28.6%
62,5210.0%0.00%
Q1 2022$28,000
-12.5%
62,5210.0%0.00%
Q4 2021$32,000
-34.7%
62,5210.0%0.00%
Q3 2021$49,000
+226.7%
62,521
+399.5%
0.00%
Q2 2021$15,000
-25.0%
12,5160.0%0.00%
Q1 2021$20,000
+122.2%
12,5160.0%0.00%
Q4 2020$9,00012,5160.00%
Other shareholders
ARTELO BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
KEYSTONE WEALTH PARTNERS 15,000$7,0000.00%
Snowden Capital Advisors LLC 110,000$49,0000.00%
Virtu Financial LLC 23,801$11,0000.00%
UBS Group AG 18,283$8,0000.00%
WELLS FARGO & COMPANY/MN 260$00.00%
NORTHERN TRUST CORP 62,521$28,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 167,826$75,0000.00%
STATE STREET CORP 13,039$6,0000.00%
CREATIVE FINANCIAL DESIGNS INC /ADV 1,075$00.00%
View complete list of ARTELO BIOSCIENCES INC shareholders